# Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

NDC: 72516-013
Generic name: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler / Manufacturer: Oryza Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201019

FDA application: ANDA210293

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 3.75 mg/1
- AMPHETAMINE SULFATE: 3.75 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 3.75 mg/1
- DEXTROAMPHETAMINE SULFATE: 3.75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72516-013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72516-013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acd27181-a3f3-4c38-85d8-029a4a82e7c2